Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Cash Flows From Operating Activities | |||||
Net Income | 6,193,000 | 2,418,000 | 3,941,000 | 4,459,000 | 11,934,000 |
Depreciation Amortization | 4,519,000 | 4,676,000 | 5,471,000 | 6,375,000 | 6,691,000 |
Income taxes - deferred | -509,000 | -2,621,000 | -1,521,000 | -764,000 | -2,600,000 |
Accounts receivable | -418,000 | 297,000 | -619,000 | -480,000 | -554,000 |
Accounts payable and accrued liabilities | 230,000 | 254,000 | 278,000 | -37,000 | 593,000 |
Other Working Capital | -1,553,000 | -5,017,000 | -2,601,000 | -268,000 | 1,824,000 |
Other Operating Activity | 2,460,000 | 6,444,000 | 5,427,000 | 3,253,000 | -9,899,000 |
Operating Cash Flow | $10,922,000 | $6,451,000 | $10,376,000 | $12,538,000 | $7,989,000 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 7,258,000 | 4,925,000 | -1,298,000 | 3,732,000 | -9,830,000 |
PPE Investments | -2,615,000 | -1,888,000 | -1,614,000 | -1,283,000 | -1,317,000 |
Net Acquisitions | -431,000 | -396,000 | -780,000 | -7,428,000 | 11,239,000 |
Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -1,000,000 |
Other Investing Activity | 102,000 | 38,000 | 482,000 | 221,000 | -466,000 |
Investing Cash Flow | $4,314,000 | $2,679,000 | $-3,210,000 | $-4,758,000 | $-374,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 5,124,000 | -26,000 | 0 | -1,540,000 | -460,000 |
Debt Issued | N/A | N/A | 1,079,000 | 7,938,000 | 3,146,000 |
Debt Repayment | -4,287,000 | -1,103,000 | -2,386,000 | -2,906,000 | -6,617,000 |
Common Stock Issued | 591,000 | 499,000 | 939,000 | 485,000 | 1,560,000 |
Common Stock Repurchased | -9,091,000 | -4,014,000 | -3,434,000 | -4,186,000 | -7,703,000 |
Dividend Paid | -5,172,000 | -5,167,000 | -5,124,000 | -5,117,000 | -5,247,000 |
Other Financing Activity | -325,000 | -195,000 | -118,000 | -61,000 | 79,000 |
Financing Cash Flow | $-13,160,000 | $-10,006,000 | $-9,044,000 | $-5,387,000 | $-15,242,000 |
Exchange Rate Effect | -205,000 | 457,000 | -131,000 | -1,310,000 | -553,000 |
Beginning Cash Position | 6,096,000 | 6,515,000 | 8,524,000 | 7,441,000 | 15,621,000 |
End Cash Position | 7,967,000 | 6,096,000 | 6,515,000 | 8,524,000 | 7,441,000 |
Net Cash Flow | $1,871,000 | $-419,000 | $-2,009,000 | $1,083,000 | $-8,180,000 |
Free Cash Flow | |||||
Operating Cash Flow | 10,922,000 | 6,451,000 | 10,376,000 | 12,538,000 | 7,989,000 |
Capital Expenditure | -2,615,000 | -1,888,000 | -1,614,000 | -1,283,000 | -1,317,000 |
Free Cash Flow | 8,307,000 | 4,563,000 | 8,762,000 | 11,255,000 | 6,672,000 |